Karen Brown
General Counsel bei PRIME MEDICINE, INC.
Profil
Karen Brown is currently the Senior VP-Intellectual Property & Legal Affairs at Prime Medicine, Inc. Previously, she held the position of Chief Intellectual Property Counsel at Ironwood Pharmaceuticals, Inc. and Senior Vice President-IP & Legal Affairs at Obsidian Therapeutics, Inc. Dr. Brown has a doctorate degree from Boston University, an undergraduate degree from Princeton University, and a graduate degree from Fordham University School of Law.
Aktive Positionen von Karen Brown
| Unternehmen | Position | Beginn |
|---|---|---|
| PRIME MEDICINE, INC. | General Counsel | - |
Ehemalige bekannte Positionen von Karen Brown
| Unternehmen | Position | Ende |
|---|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Obsidian Therapeutics, Inc.
 Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | General Counsel | - |
Ausbildung von Karen Brown
| Princeton University | Undergraduate Degree |
| Boston University | Doctorate Degree |
| Fordham University School of Law | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| PRIME MEDICINE, INC. | Health Technology |
| IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | Health Technology |
